Report shows no-deal Brexit is still a “highly uncertain environment”
The National Audit Office report states that despite the extensive preparations, there still remains a “significant amount to do before 31 October.”
Read Moreby Anna Smith | Sep 30, 2019 | News | 0
The National Audit Office report states that despite the extensive preparations, there still remains a “significant amount to do before 31 October.”
Read Moreby Anna Smith | Jul 30, 2019 | News | 0
Johnson also took a moment in his speech to announced that he wants to revisit and potentially reverse the sugar tax.
Read Moreby Anna Smith | Jun 28, 2019 | News | 0
Niall Dickson, chief executive of the NHS Confederation, expressed concerns about the plans.
Read Moreby Anna Smith | Apr 1, 2019 | News | 0
The ABPI has warned that “there a range of things outside of our control”.
Read Moreby Anna Smith | Mar 26, 2019 | News | 0
Sanofi has said that it could potentially airlift its flu vaccine into the UK in the event of a no-deal Brexit.
Read Moreby Anna Smith | Mar 13, 2019 | News | 0
An international survey commissioned by the Royal Society of Chemistry has revealed the scale of Brexit concern in the sector across the UK, EU and beyond.
Read Moreby Anna Smith | Jan 24, 2019 | News | 0
Novo Nordisk says it has planned for all future ‘no-deal’ Brexit contingencies, including doubling UK stock to 16 weeks (around four months of supply), which will be in place by the end of January.
Read Moreby Anna Smith | Jan 4, 2019 | News | 0
In advance of the UK leaving the European Union on 29 March 2019, the Medicines and Healthcare products Regulatory Agency (MHRA) has released a statement detailing its preparations for the event of a no-deal Brexit scenario.
Read Moreby Selina McKee | Dec 10, 2018 | News | 0
The pharmaceutical industry is calling on the government to urgently provide more detail on how it plans to ensure a continued supply of medicines should the UK leave the EU under a ‘no-deal’ scenario.
Read Moreby Selina McKee | Oct 11, 2018 | News | 0
Pharmaceutical companies “are doing everything in their power” to minimise disruption to the supply of medicines should the UK leave the EU under a ‘no-deal’ scenario, but a deal is urgently needed to fully protect patients, MPs have been told.
Read Moreby Selina McKee | Oct 5, 2018 | News | 0
The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its legislation and regulatory processes would have to be modified if the UK leaves the EU under a ‘no-deal’ scenario.
Read Moreby Selina McKee | Aug 24, 2018 | News | 0
The government has asked drug manufacturers to increase stockpiles of medicines to ensure continued supply in the event that the UK leaves the EU in a ‘no-deal’ scenario.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
